Central Pharmaceutical Joint Stock Company No3: 2024 net revenue rose 1.9% and gross margin improved, but net profit slipped 3.3%

About this update from Central Pharmaceutical Jsc No. 3

Net revenue grew 1.9% to VND 417.5 billion in 2024, while net profit after tax declined 3.3% to VND 121.2 billion. Gross margin improved to 33.9%, and cash position strengthened, with a dividend payout of VND 64.5 billion.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Central Pharmaceutical Jsc No. 3